No longer limited to the realm of science fiction, bio-computing is here, so now is the time to start considering how to research and apply this technology responsibly, an international group of experts says.
Diet treatments are often used with the aim of reducing seizure frequency and severity — but they may have other benefits as well. Joy Mazur spoke with Dr. Magnhild Kverneland about the possible effect of dietary treatments on emotional symptoms and their correlation with health-related quality of life.
“There is abundant evidence of a link between contact sports, such as football, and dementia later in life,” comments Domenico Pratico, M.D., Director of the Alzheimer’s Center at Temple University (ACT).
A recent study shows that a protein called ABCA7 plays a functional role as a potential biological link between cholesterol and inflammation in Alzheimer’s disease. The new work was published online August 25 in the journal Cells.
Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells.
The Neurosurgery Research & Education Foundation (NREF) is pleased to announce this year’s recipients of the Foundation’s Research Fellowship Grants and Young Clinician Investigator Awards.
Fundamental questions of agency – acting with purpose – have perplexed some of the greatest minds in history including Sir Isaac Newton and Charles Darwin. Now, human babies provide groundbreaking insight into the origins of agency.
Ongoing work by Florida State University College of Medicine researchers into how aspartame affects the brain has linked the artificial sweetener with learning and memory deficits in mice.
A $750,000 philanthropic grant from the Carl Angus DeSantis Foundation will help FAU develop partnerships and programs that will establish best practice for coordinated care and research for Alzheimer’s disease and related dementias.
In a new study, published in Pediatrics, researchers at the Center for Injury Research and Policy and Central Ohio Poison Center at Nationwide Children’s Hospital investigated the characteristics and trends of out-of-hospital ADHD medication errors among people younger than 20 years old reported to U.S. poison centers from 2000 through 2021.
El lecanemab ha llamado la atención en todo el mundo por ser el medicamento aprobado recientemente para la enfermedad de Alzheimer y el primer tratamiento aprobado por la FDA para el alzhéimer en más de 20 años.
O lecanemabe recebeu atenção mundial depois de ter sido o medicamento mais recente aprovado para a doença de Alzheimer e o primeiro tratamento aprovado para Alzheimer pela Administração de Alimentos e Medicamentos (Food and Drug Administration, FDA) dos EUA em mais de 20 anos.
مدينة روتشستر، ولاية مينيسوتا — حظى دواء ليكانيماب باهتمام عالمي كأحدث خيار علاجي معتمد للتعامل مع داء الزهايمر وأول دواء معتمد من إدارة الغذاء والدواء الأمريكية منذ أكثر من 20 عامًا. دونانيماب، هو دواء آخر من نفس الفئة في طور المراجعة للحصول على الاعتماد نفسه. ويتوقع أن يُعتمد خلال هذا العام. يقول فيجاي رامانان، دكتور في الطب، حاصل على دكتوراه اختصاصي الأعصاب السلوكي في مايو كلينك في مدينة روتشستر، بولاية مينيسوتا أنه من المهم النظر إلى هذه الخيارات الجديدة كجزء محتمل من خطة علاجية شاملة.
Scientists at Peter the Great St. Petersburg Polytechnic University demonstrated that optogenetic stimulation of hippocampal astrocytes can have a positive effect on the course of the Alzheimer's disease. At the very least, it worked in a mouse model of the disease.
It is a heartbreaking condition that robs children of their ability to walk, talk and recognise their loved ones and now the latest research has revealed the true impact of childhood dementia globally.
The targeted use of ultrasound technology can bring about significant changes in brain function that could pave the way towards treatment of conditions such as depression, addiction, or anxiety, a new study suggests.
Traditional MRI scans provide qualitative images that necessitate subjective interpretation by medical professionals.
A new Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration of dopaminergic neurons is widely accepted as the first event that leads to Parkinson’s.
Scientists have confirmed that human brains are naturally wired to perform advanced calculations, much like a high-powered computer, to make sense of the world through a process known as Bayesian inference.
A new study finds poor quality of available foods, increased intake of calories from foods high in trans-fatty acids, and environments that do not foster physical activity, disrupt the flexibility of information processing in the brain that is involved in reward, emotion regulation, and cognition.
UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and neurodegeneration markers in people who suffer from multiple sclerosis (MS). In addition, they also found this dietary supplement improved neurological function in 30% of patients.
Researchers at The Ohio State University Wexner Medical Center and led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.
In a newly published paper in Blood, researchers from Sylvester Comprehensive Cancer Center and collaborating organizations clarify current treatment approaches in the management of patients with secondary central nervous system lymphoma (SCNSL) caused by aggressive lymphoma.
R.Á.P.I.D.O., a culturally relevant acronym created under the leadership of Jennifer Beauchamp, PhD, RN, at Cizik School of Nursing at UTHealth Houston to raise awareness of stroke signs in the Spanish-speaking Hispanic/Latino community and save lives, has been adopted by the American Stroke Association (ASA), the organization announced today.
Nearly one in five people on Medicare travel 50 or more miles one way to see a neurologist, a doctor who diagnoses and treats diseases of the brain and nervous system, according to research published in the September 13, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology (AAN).
Some published data suggest that besides their effect on cholesterol, statins also may play a protective role in some neurological disorders, including epilepsy. Dr. Bruna Nucera interviews Dr. Anthony Marson and Dr. Emilio Russo about whether and how to test statins as potential anti-epileptogenic drugs.
A multidisciplinary team of researchers will use the fruit fly, Drosophila melanogaster, to study how the brain forms a coherent representation from multisensory information, corrects for errors from perturbations and generates robust behaviors.
Unruptured cerebral aneurysms of sizes and locations that require attention may be frequently missed in routine clinical care, but a machine learning algorithm could minimize missed care opportunities, according to a new study from UTHealth Houston.
The new University of Chicago Healthy Aging & Alzheimer's Research Care (HAARC) Center will focus on building deep multidisciplinary expertise and bridging the gap between scientific disciplines to accelerate breakthroughs in cognitive resilience.
Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals.
Using gene therapy to treat many neurologic diseases, such as Alzheimer’s and Parkinson’s, has long been a long-sought goal of researchers, but the blood-brain barrier has proven very difficult to cross.
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.
Focused ultrasound technology holds promise for treating millions suffering from addiction.
Scientists from Immanuel Kant Baltic Federal University and Institute of Higher Nervous Activity and Neurophysiology of RAS have described in detail disturbances in rhythm of brain that are observed among patients with Rett syndrome – severe genetical disorder, that leads to decline of mental abilities, memory and ability to control movements.
Newly approved anti-amyloid therapies that slow Alzheimer’s disease progression offer new hope for people with the disorder.
The Richmond, Virginia-based Red Gates Foundation recently committed $50 million to the Fralin Biomedical Research Institute at VTC to accelerate health sciences research at Virginia Tech. The gift is among the largest ever made to the university.
Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a significantly increased risk of ischemic stroke in a diverse group of U.S. adults, according to new research being presented at the 148th Annual Meeting of the American Neurological Association (ANA). Suffering more than one head injury further increased the risk.
Even the best treatment approaches for Parkinson’s disease are inadequate if they do not address patients’ feelings of social rejection, isolation, loneliness and other psychosocial effects of stigma, according to a report from experts specializing in Parkinson’s and other movement disorders.
The zebrafish brain, though simpler than its human counterpart, is a complex network of neurons that engage in a ceaseless dance of electrical activity. What if this neural ballet could reveal the secrets of how brains, including our own, control movement?
Breakthrough platform opens new possibilities for treating neurological diseases, including paralysis.
Nearly 100 drugs for multiple sclerosis (MS), blood cancers, rheumatoid arthritis and other diseases may cause Progressive Multifocal Leukoencephalopathy (PML), a rare but often-fatal condition. A simple genetic test can determine who has a 10-fold higher risk for the condition so they can discuss safer treatment options with their physicians. The largest study to date on drugs that increase the risk for PML and the genetic link to the disease is being presented at the 148th Annual Meeting of the American Neurological Association (ANA).
Neurological disorders – including autism spectrum disorder (ASD), Alzheimer’s disease and Parkinson’s disease – cause sleep disturbances that make life extra challenging for people with those conditions. Improving sleep not only helps improve their quality of life, evidence is mounting that good sleep is vital for a healthy brain and may reduce the risk of some neurological disorders, according to neurologists speaking at the Presidential Symposium – Exploring Sleep Disturbances in CNS Disorders plenary session at the 148th Annual Meeting of the American Neurological Association (ANA).
Credentialed press representatives are invited to attend the Congress of Neurological Surgeons 2023 Annual Meeting in Washington, DC.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Colin Franz as one of the 2023 Scientific Impact Award.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Monika Krzesniak-Swinarska as the 2023 Ernest Johnson Outstanding Educator Award recipient for her unwavering dedication to education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
Rochester, Minn. (Sept. 09, 2023)- The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. David R. Cornblath as the 2023 Distinguished Researcher Award recipient for his contributions to the study of peripheral neuropathies and his extensive research in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Teresa Spiegelberg, CNCT, R.NCS.T., R.EEG.T, BS, as the inaugural Outstanding Service Award recipient for her dedicated service to patients, medical education, and AANEM.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Amanda C. Peltier as the 2023 Jun Kimura Outstanding Educator Award recipient for her numerous contributions and dedication to advancing medical education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Brooke Eby as the 2023 Public Recognition Award recipient for her remarkable commitment to raising awareness about muscle and nerve disorders, specifically amyotrophic lateral sclerosis (ALS).
Rochester, Minn. (Sept. 09, 2023)- The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Bassam A. Bassam as the 2023 Distinguished Physician Award recipient for his exceptional contributions to patient care, research, and education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
